Zobrazeno 1 - 10
of 170
pro vyhledávání: '"G. Doelken"'
Autor:
M, Sieber, H, Tesch, B, Pfistner, U, Rueffer, U, Paulus, R, Munker, R, Hermann, G, Doelken, P, Koch, J, Oertel, S, Roller, P, Worst, H, Bischof, A, Glunz, R, Greil, K, von Kalle, K P, Schalk, D, Hasenclever, O, Brosteanu, E, Duehmke, A, Georgii, A, Engert, M, Loeffler, V, Diehl, R P, Mueller, N, Willich, R, Fischer, M L, Hansmann, H, Stein, T, Schober, B, Koch
Publikováno v:
Annals of Oncology. 15:276-282
Background: The purpose of this study was to compare the efficacy of the hybrid chemotherapeutic regimen COPP/ABV/IMEP (cyclophosphamide–vincristine–procarbazine–prednisone–doxorubicin–bleomycin–vinblastine–ifosfamide–methotrexate–e
Publikováno v:
Journal of Hospital Infection. 53:283-291
Patients undergoing cancer chemotherapy frequently suffer from mucositis, particularly if they become leukopenic (leucocytes1000/microL). To identify a possible benefit from antiseptic rinsing of the oral cavity, 47 patients were randomized to rinse
Autor:
V. Diehl, M. Loeffler, M. Pfreundschuh, U. Ruehl, D. Hasenclever, H. Nisters-Backes, M. Sieber, K. Smith, H. Tesch, W. Geilen, M. Adler, H. Bartels, U. Brandenburg, P. Diezler, G. Doelken, J. Enzian, R. Fuchs, W. Gassmann, H. Gerhartz, U. Hagenaukamp, T. Hecht, E. Hiller, H. Hinkelbein, B. Lathan, H. Kirchner, G. Kuehn, H. Kuerten, U. Loos, B. Makoski, W. Oertel, S. Petsch, R. Pfab, H. Pflueger, M. Planker, R. Rohioff, H. Sack, S. Samandari, R. Sauer, K. Schalk, G. Schmitz, W. Schoppe, G. Schwieder, S. Szepesi, J. Teichmann, W. Wilhelmy, P. Worst, R. Fischer, A. Georgii, K. Huebner, E.W. Schwarze, R. Rohloff, U. Hagen-Aukamp, H. Kürten, M. Westerhausen, H. Pflüger, J. Entzian, G. Dölken, H. Ernst, J. König, H. Hellriegel, G. Kühn, U. Rühl, null Szepesi, U. Schulz, S. Theml, R. Staiger, W. Haase, T. Wagner, null Brandenburg, I. Boldt, H.J. Schmoll, H. Emminger, W. Gaβmann, T. Brix, B. Mödder, H. Hennekeuser, G. Schlimok, null Doukas, A.-C. Voss, B. Krüger, K. Kutzner, F. Hinrichs, A. Temmesfeld, T. Luska, H.D. Schick, J. Preiβ, W. Gärtner, W. Mende, W. Alberti, U. Hoffmann, D. Urbanitz, null Heide, H. Siebner, K.H. van de Weyer, D. Dornoff, E. Renner, M. Cohen, P. Czygan, H.W. Scheja, J. Schoenemann, M. Rochell, U. Peters, K. Koniczek, D. Mitrenga, U. Cammerer, W. Mantel, K. Hübner, Volker Diehl
Publikováno v:
Annals of Oncology. 6:901-910
Summary Objective It was the aim of this prospective randomized multicenter study to compare chemotherapy and radiotherapy as consolidation treatments in patients achieving complete remission (CR) after 6 cycles of doxorubicin-containing chemotherapy
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Clinical Oncology. 20:4397-4398
Autor:
G. Doelken, Marita Ziepert, B. Glass, Mathias Haenel, Michael Pfreundschuh, Lorenz Truemper, Norma Peter, Christian M. Schmidt, Maike Nickelsen, Martin Bentz, Peter Borchmann, N. Schmitz, Andreas Viardot, G. Ehninger, M. Loeffler
Publikováno v:
Journal of Clinical Oncology. 29:8002-8002
8002 Background: Studies comparing HDT with conventional first-line therapy for younger patients (pts.) with aggressive B-cell lymphoma gave conflicting results. None of these studies combined chemotherapy with Rituximab (R). Methods: In younger pts.
Autor:
Thoralf Lange, H.-H. Wolf, Christian Junghanss, Thomas M. Fischer, Peter Dreger, Lutz Uharek, D. Hähling, Ute Kreibich, Michael Herold, H. K. Al-Ali, Herbert G. Sayer, Wolfram Pönisch, Rainer Krahl, Dietger Niederwieser, G. Doelken, U Hegenbart, C. Nehring, Georg Maschmeyer, Norbert Grobe, R. Kortmann
Publikováno v:
Journal of Clinical Oncology. 29:6523-6523
6523 Background: Complete remission rates similar to those of younger pts are obtained in elderly AML pts (OSHO AML 1997). However, OS and LFS remain dismal because of extremely high relapse rates....
Autor:
Wolfram Pönisch, Thoralf Lange, Michael Herold, Ruediger Hehlmann, Achim Heinecke, Dietger Niederwieser, Markus Pfirrmann, Verena S. Hoffmann, Rainer Krahl, Wolfgang E. Berdel, Vladan Vucinic, Georg Maschmeyer, Maria-Cristina Sauerland, G. Doelken, Thomas M. Fischer, H. K. Al-Ali, Dieter Hoelzer, Christian Junghanss, T. Büchner, Herbert G. Sayer
Publikováno v:
Journal of Clinical Oncology. 29:6618-6618
6618 Background: Until recently, elderly patients with AML were treated in protocols for younger pts or outside protocols. In order to evaluate the outcome of these pts in more detail, an intergrou...
Autor:
Georg Maschmeyer, H.-H. Wolf, Christian Junghanss, G. Doelken, Ute Kreibich, F. Schueler, Dietger Niederwieser, U Hegenbart, Herbert G. Sayer, Oncology Osho, Thomas M. Fischer
Publikováno v:
Journal of Clinical Oncology. 28:6505-6505
6505 Background: Acquired mutations of the flt3 and npm1 genes have been shown to determine outcome in younger pts with AML. Here, the influence of flt3 and npm1 mutations on outcome of elderly pts (> 60 a) was analyzed in relation to either chemothe
Autor:
Erika Kettner, Norma Peter, Cornelia Becker, W. Helbig, Axel Florschuetz, Ute Kreibich, A. Franke, Michael Cross, H.K. Al Ali, Manfred Schulze, Heiner Wolf, U. Mahlknecht, Dietger Niederwieser, A. Gerhardt, L Uharek, Detlev Haehling, U. Wedding, G. Doelken, Wolfram Poenisch, Antje Schulze, Simone Heyn, Bernhard Opitz, R. Krahl, N. Zojer, Ernst Zschuppe, M. Freund
Publikováno v:
Blood. 110:1854-1854
The incidence of AML increases with age. More than half of the patients (pts) are over 60 years (y) at time of diagnosis. On the other hand, elderly pts are clearly under-represented in the literature. The AML 97 study was designed to register all pt